IDEXX Laboratories (FRA:IX1) Float Percentage Of Total Shares Outstanding: 87.48% (As of Jul. 01, 2026)


FRA:IX1 IDEXX Laboratories Inc FRA:IX1
96 GF Score
Price €469.00
GF Value €562.69
Valuation Modestly Undervalued
View Full Analysis

What is IDEXX Laboratories Float Percentage Of Total Shares Outstanding?

IDEXX Laboratories FRA:IX1 -0.11% 96 Float Percentage Of Total Shares Outstanding is 87.48% as of Jul. 01, 2026. GuruFocus rates FRA:IX1 with a GF Score™ of 96/100 and a GF Value™ of €562.69 (Modestly Undervalued).

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IDEXX Laboratories's float shares is 69.00 Mil. IDEXX Laboratories's total shares outstanding is 78.88 Mil. IDEXX Laboratories's float percentage of total shares outstanding is 87.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IDEXX Laboratories's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IDEXX Laboratories's Institutional Ownership is 70.68%.

FRA:IX1
96GF Score
IDEXX Laboratories Inc FRA:IX1
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

IDEXX Laboratories's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=69.00/78.88
=87.48%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 87.48% mean?
IDEXX Laboratories (FRA:IX1) has a Float Percentage Of Total Shares Outstanding of 87.48% as of Jul. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on IDEXX Laboratories and its competitors.
Is IDEXX Laboratories' Float Percentage Of Total Shares Outstanding too high?
IDEXX Laboratories' current Float Percentage Of Total Shares Outstanding is 87.48%. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Float Percentage Of Total Shares Outstanding compare to A and NTRA?
IDEXX Laboratories' Float Percentage Of Total Shares Outstanding of 87.48% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Diagnostics & Research company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Diagnostics & Research industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Float Percentage Of Total Shares Outstanding is 87.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (FRA:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €562.69, compared to a current price of €469.00 — trading 16.7% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 87.48%. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For IDEXX Laboratories (FRA:IX1), the current Float Percentage Of Total Shares Outstanding is 87.48% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (FRA:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €469.00 is trading 16.7% below its estimated GF Value™ of €562.69. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:IX1:

  • Float Percentage Of Total Shares Outstanding: 87.48%
  • GF Value™: €562.69 vs. price of €469.00 (16.7% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the FRA:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for FRA:IX1

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€469.00
Price
€562.69
GF Value